NASDAQ: BOLD
Boundless Bio Inc Stock Ownership - Who owns Boundless Bio?

Insider buying vs selling

Have Boundless Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BOLD insiders and whales buy or sell their stock.

BOLD Shareholders

What type of owners hold Boundless Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.84%3,098,071$3.87MInstitution
Nextech Invest Ltd5.49%1,228,069$1.54MInstitution
Arch Venture Fund IX LP5.28%1,181,766$1.48MInsider
Kristina Burow5.28%1,181,766$1.48MInsider
Keith Crandell5.28%1,181,766$1.48MInsider
Citadel Advisors LLC3.92%876,412$1.10MInstitution
Sectoral Asset Management Inc3.03%678,574$848.22kInstitution
Jonathan E. Lim2.92%653,479$816.85kInsider
Vanguard Group Inc2.54%569,657$712.07kInstitution
Wellington Biomedical Innovation Master Investors Cayman I LP2.48%556,233$695.29kInsider

1 of 3

BOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLD42.98%23.82%
RLYB40.46%59.54%
DARE3.80%96.20%
IGC5.86%21.67%
SNTI18.58%81.42%Net Buying

Boundless Bio Stock Ownership FAQ

Who owns Boundless Bio?

Boundless Bio (NASDAQ: BOLD) is owned by 42.98% institutional shareholders, 23.82% Boundless Bio insiders, and 33.20% retail investors. Arch Venture Fund IX LP is the largest individual Boundless Bio shareholder, owning 1.18M shares representing 5.28% of the company. Arch Venture Fund IX LP's Boundless Bio shares are currently valued at $1.47M.

If you're new to stock investing, here's how to buy Boundless Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.